Journal profile · Toxicology
Biomarkers
ISSN 1354-750X · eISSN 1366-5804 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 1996
Biomarkers: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.29; subscription journal; APC charged, amount not published; median 106 days to acceptance (95 articles, last 24 months); community-reported acceptance: about 75%; 59 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biomarkers is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Carcinogens and Genotoxicity Assessment, Environmental Toxicology and Ecotoxicology and MicroRNA in disease regulation, together about 26% of its articles. Its main subfields are Health, Toxicology and Mutagenesis. (generated from OpenAlex topic counts and CAS ranking data)
The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source. Biomarkers provides a vital forum for the exchange of ideas and concepts in all areas of biomarker research. High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged: Biomarkers of disease Biomarkers of exposure Biomarkers of response Biomarkers of susceptibility Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro. Biomarkers will consider publishing negative data from studies of biomarkers of susceptibility in human populations. The emphasis will be on demonstrating relationships between markers and effects rather than methodological papers unless they describe novel techniques. We particularly also welcome clinical trials and population based studies, as well as methodologically sound literature reviews.
From the journal's Aims & Scope
Research area (LetPub): Toxicology
Editor-in-chief Martin Möckel CharitéPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology12.4%
- Environmental Toxicology and EcotoxicologyEnvironmental Science8.4%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.2%
- Air Quality and Health ImpactsEnvironmental Science5.1%
- Toxic Organic Pollutants ImpactEnvironmental Science5%
- Glutathione Transferases and PolymorphismsBiochemistry, Genetics and Molecular Biology5%
- Pesticide Exposure and ToxicityAgricultural and Biological Sciences4.3%
- Heavy Metal Exposure and ToxicityEnvironmental Science4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASCurrent ContentsPublisher website
Other: Index Medicus, Biological Abstracts, Bioscience Information Service, Biotechnology Abstracts, Current Awareness in Biological Sciences (CABS), Excerpta Medica, PASCAL, Research Alert, SciSearch, Sociedad Iberoamericana de Información Científica (SIIC), UnCover
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.29LetPub ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.5LetPub ·
- CiteScore (publisher) 2025
- 4.5Publisher website ·
- SJR 2026-06
- 0.59LetPub ·
- SJR (publisher) 2025
- 0.59Publisher website ·
- SNIP 2026-06
- 0.61LetPub ·
- SNIP (publisher) 2025
- 0.61Publisher website ·
- h-index
- 61LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 1,342OpenAlex ·
- 2-year mean citedness
- 2.55OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4.38%LetPub ·
Volume
- Articles per year
- 50LetPub ·
- Downloads per year (publisher)
- 97,000Publisher website ·
Articles by year OpenAlex count · 2,318 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 7 | 12 |
| 2025 | 59 | 9 | 158 |
| 2024 | 75 | 29 | 299 |
| 2023 | 48 | 8 | 295 |
| 2022 | 83 | 13 | 785 |
| 2021 | 130 | 27 | 1,256 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
106 daysMedian, submission to acceptance · P25–P75 74 days – 151 days
- Acceptance to online
- median 22 days (95 articles)
- Submission to online
- median 141 days
- Sample
- 95 articles with submission and acceptance dates (129 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Acceptance rate (publisher)
- 8%Publisher website ·
- Submission to first decision
- 16 daysPublisher website ·
- First decision after review
- 52 daysPublisher website ·
- Acceptance to publication
- 30 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Hybrid open access journal (Open Select) Model summary
Biomarkers is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership o…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1996
- ISSN
- 1354-750X
- Electronic ISSN
- 1366-5804
- Latest issue on the website
- Volume 31, Issue 6 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Biomarkers
What CAS zone is Biomarkers in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biomarkers is in Zone 4 of Medicine, and in Zone 4 of the minor category Biotechnology & Applied Microbiology / Toxicology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biomarkers?
The latest impact factor listed by LetPub is 2.29; CiteScore 4.5, h-index 86.
How long does peer review take at Biomarkers?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 106 days (interquartile range 74–151 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”; the journal's website gives an acceptance rate of 8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biomarkers?
According to LetPub and DOAJ records, Biomarkers is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, CAS and Current Contents; that list has not been checked against each database.
Is Biomarkers open access, and what is the APC?
Biomarkers is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .